The effects of customer relationships and social capital on firm performance: a Chinese business illustration
Article Abstract:
The relationship between customer relationships, business-partner social capital and governing-agency social capital and its influence on a firm's performance is examined.
Publication Name: Journal of International Marketing
Subject: Business, international
ISSN: 1069-031X
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
The litigated dissolution of international distribution relationships: a process framework and propositions
Article Abstract:
A study on dissolution of international collaborations due to litigations among parties is discussed.
Publication Name: Journal of International Marketing
Subject: Business, international
ISSN: 1069-031X
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Exploring the marketing program antecedents of performance in a global company
Article Abstract:
The various factors, drivers and consequences, pertaining to global marketing programs are examined.
Publication Name: Journal of International Marketing
Subject: Business, international
ISSN: 1069-031X
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The new customer relationship management tool - product elimination? Retaining customers in UK financial services: The retailers' tale
- Abstracts: New operations research and artificial intelligence approaches to traffic engineering problems. Solving machine-loading problem of a flexible manufacturing system with constraint-based genetic algorithm
- Abstracts: Daimler official faces an inquiry on insider trades. Trading in Daimler shares is probed. Daimler profits jump, SEC starts probe
- Abstracts: H-P shifts focus to retail printing with photo kiosks. H-P net jumps amid a shift in strategic focus. Gateway to pay Hewlett-Packard $47 million in patent settlement
- Abstracts: Europe's drug insurers try pay-for-performance. FDA seeks more study of Novartis medication